Filing Flows › Teladoc Health (TDOC) › Q3 2026
Teladoc Health (TDOC) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 29, 2026
Teladoc Health (TDOC) reported revenue of $605M for the third quarter 2026 (Q3 2026), -3% from a year earlier and -0.3% from the quarter before. Operating margin was -4.6%, net loss $26.9M (4.5% of revenue).
Teladoc Health, Q3 2026: revenue $605M (-3% year over year), operating margin -4.6%, net loss $26.9M, operating cash flow $106M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $605M | -0.3% | -3% |
| Operating profit | −$28.1M | — | — |
| Net earnings | −$26.9M | — | — |
| Operating cash flow | $106M | +65% | +7% |
| Free cash flow | $105M | +65% | +9% |
What changed
Revenue was $605.1M in Q3 2026, down 3% year over year and roughly flat from the previous quarter. Access Fees was the largest line at 77% of revenue. Access Fees lost $54.2M year over year (down 10%), 254% of the total change.
Operating costs exceeded revenue by $28.1M, an operating margin of -4.6%. Total costs fell 7% while revenue fell 3%. The quarter ended with a net loss of $26.9M, narrower than the previous quarter's $38.9M loss.
Operating cash flow was $106.5M (up 7% year over year). Non-cash charges added back $11.6M of share-based compensation. Working capital and other items added $121.8M. Capital expenditures of $1.2M left free cash flow of $105.2M.
Questions
What was Teladoc Health's revenue in the third quarter 2026?
Teladoc Health (TDOC) reported revenue of $605M for the third quarter 2026 (Q3 2026), -3% from a year earlier and -0.3% from the quarter before.
Was Teladoc Health profitable in the third quarter 2026?
Operating loss was $28.1M (-4.6% of revenue) and net loss $26.9M.
Source: Teladoc Health 10-Q on SEC EDGAR.